Literature DB >> 32820014

Prevalence and incidence rates of atrial fibrillation in Norway 2004-2014.

Lars Jøran Kjerpeseth1, Jannicke Igland2, Randi Selmer1, Hanne Ellekjær3,4, Arnljot Tveit5,6, Trygve Berge5, Silje Madeleine Kalstø5, Ingrid Elisabeth Christophersen5,7, Marius Myrstad5, Eva Skovlund1,8, Grace Margrethe Egeland2,9, Grethe Seppola Tell1,2, Inger Ariansen10.   

Abstract

OBJECTIVE: To study time trends in incidence of atrial fibrillation (AF) in the entire Norwegian population from 2004 to 2014, by age and sex, and to estimate the prevalence of AF at the end of the study period.
METHODS: A national cohort of patients with AF (≥18 years) was identified from inpatient admissions with AF and deaths with AF as underlying cause (1994-2014), and AF outpatient visits (2008-2014) in the Cardiovascular Disease in Norway (CVDNOR) project. AF admissions or out-of-hospital death from AF, with no AF admission the previous 10 years defined incident AF. Age-standardised incidence rates (IR) and incidence rate ratios (IRR) were calculated. All AF cases identified through inpatient admissions and outpatient visits and alive as of 31 December 2014 defined AF prevalence.
RESULTS: We identified 175 979 incident AF cases (30% primary diagnosis, 69% secondary diagnosis, 0.6% out-of-hospital deaths). AF IRs (95% confidence intervals) per 100 000 person years were stable from 2004 (433 (426-440)) to 2014 (440 (433-447)). IRs were stable or declining across strata of sex and age with the exception of an average yearly increase of 2.4% in 18-44 year-olds: IRR 1.024 (1.014-1.034). In 2014, the prevalence of AF in the adult population was 3.4%.
CONCLUSIONS: We found overall stable IRs of AF for the adult Norwegian population from 2004 to 2014. The prevalence of AF was 3.4% at the end of 2014, which is higher than reported in previous studies. Signs of an increasing incidence of early-onset AF (<45 years) are worrying and need further investigation. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  atrial fibrillation; epidemiology

Year:  2020        PMID: 32820014     DOI: 10.1136/heartjnl-2020-316624

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

1.  Population Attributable Risks of Potential Modifiable Factors for Atrial Fibrillation in China: A National Survey.

Authors:  Zhiqiang Nie; Hongbin Xu; Chen Chen; Yong Gan; Guo Chen; Chao Wang; Wei Yue; Feng Yan; Yingqing Feng; Zuxun Lu
Journal:  Risk Manag Healthc Policy       Date:  2022-06-14

2.  Association between complete right bundle branch block and atrial fibrillation development.

Authors:  Fu-Tao Zhang; Xiao-Jie Liu; Dan-Qing Zhao; Jin-Tao Wu; Lei-Ming Zhang; Juan Hu; Xian-Wei Fan; Hai-Tao Yang; Li-Jie Yan; Jing-Jing Liu; Shan-Ling Wang
Journal:  Ann Noninvasive Electrocardiol       Date:  2022-05-14       Impact factor: 1.485

3.  The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics.

Authors:  Mika Lehto; Olli Halminen; Pirjo Mustonen; Jukka Putaala; Miika Linna; Janne Kinnunen; Elis Kouki; Jussi Niiranen; Juha Hartikainen; Jari Haukka; Kari Eino Juhani Airaksinen
Journal:  Eur J Epidemiol       Date:  2022-01-05       Impact factor: 8.082

4.  Association of Depression With Atrial Fibrillation in South Korean Adults.

Authors:  Yun Gi Kim; Kwang-No Lee; Kyung-Do Han; Kyu-Man Han; Kyongjin Min; Ha Young Choi; Yun Young Choi; Jaemin Shim; Jong-Il Choi; Young-Hoon Kim
Journal:  JAMA Netw Open       Date:  2022-01-04

5.  Atrial fibrillation is associated with increased risk of lethal ventricular arrhythmias.

Authors:  Yun Gi Kim; Yun Young Choi; Kyung-Do Han; Kyongjin Min; Ha Young Choi; Jaemin Shim; Jong-Il Choi; Young-Hoon Kim
Journal:  Sci Rep       Date:  2021-09-13       Impact factor: 4.379

6.  Examining the lower range of the association between alcohol intake and risk of incident hospitalization with atrial fibrillation.

Authors:  Inger Ariansen; Eirik Degerud; Knut Gjesdal; Grethe S Tell; Øyvind Næss
Journal:  Int J Cardiol Heart Vasc       Date:  2020-11-29

Review 7.  Mitochondrial Dysfunction in Atrial Fibrillation-Mechanisms and Pharmacological Interventions.

Authors:  Paweł Muszyński; Tomasz A Bonda
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.